Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. - Wikidata - awgldk - TriplyDB

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

http://www.wikidata.org/entity/Q41729344

about

Interventions for bronchiectasis: an overview of Cochrane systematic reviews Primary ciliary dyskinesia.Bronchiectasis in the Last Five Years: New Developments The EMBARC European Bronchiectasis Registry: protocol for an international observational study Bronchiectasis and Aspergillus: How are they linked?What's new in the management of adult bronchiectasis?Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with Bronchiectasis Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.Emerging drugs for bronchiectasis: an update.Year in review 2014. Paediatric and adult clinical studies.Challenges in the development of new therapies for bronchiectasis.An update on pediatric bronchiectasis.Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.Bronchiectasis: Phenotyping a Complex Disease.Diagnosis and management of bronchiectasis.Bronchiectasis in China.Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study.Update in Bronchiectasis 2014.Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence.A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age.Reclaiming the name 'bronchiectasis'.The pharmacological treatment of bronchiectasis."The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations Non-cystic fibrosis bronchiectasis in the elderly: current perspectives

P2860

Q24186645-483FC95D-546E-4BE2-93FC-D88D19754301 Q27333212-A18F3E35-4626-426A-9362-EBD563D76E5A Q28075732-F2F33072-4217-436A-9332-40E9AD98BCD4 Q28596688-FA89294A-AC06-46AC-98FB-052DFC0EFD51 Q30243947-869216DD-CB4F-45E0-A25A-EA132FFB3FF3 Q33589288-2D2D872B-DCD4-4614-BCCB-CE6387BD7290 Q33780616-1D6CD453-8009-4E0A-AFD3-ADADDA24A2C2 Q35764823-6CD2E426-6CDC-4E7B-B939-8AE0FDB2C3CD Q36692961-E92517B3-911A-447A-BAA9-B1F9AE9026C7 Q38367379-D47A199B-8131-4E74-90C0-986F7D23B4CF Q38376166-5EBDC119-4154-4906-99FF-F3C750A781C4 Q38387657-057F3E3D-6D48-4F87-A534-3CBCB771B858 Q38679480-016A056C-67F0-4ACA-987D-82012DE7AF5F Q38797806-A14ECCE3-330A-461E-BB9A-3D2578486589 Q38901227-560DE9B9-DB6D-4D12-822D-2F1BB1B801DA Q39384458-17732F80-FABA-41E0-A008-F18831199CE8 Q39993355-38A5663C-9CDD-4EEB-B6D3-079D90497D7D Q40352533-9BD1F73A-8F73-480A-A28B-9CC07BE49D58 Q41122996-72AB2507-50EF-4E42-A44B-5709C71908C4 Q47113028-434C843A-F467-4AAA-B6ED-F8118245F28E Q48335145-9B5BA4D0-976E-4198-8C48-B58FC50667E9 Q51648266-CE4082BD-C6F7-4BFC-B0DF-154B277D472E Q51751531-B21D1727-21FE-4FFE-AFDA-6F4CCAA586E4 Q55350869-BA75A516-D348-4010-A59C-DB0D866D0E14 Q57092123-F6D1C132-8980-46CF-9E2F-5E389E1B29BC Q57646591-73AC731A-D0F9-487B-95D5-37DECFB23381

P2860

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

http://www.wikidata.org/entity/Q41729344

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

@en

type

label

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

@en

prefLabel

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

@en

P1433

Q41729344-320E5A5B-E153-405D-91A0-7BEC89A09CBC

P1476

Q41729344-E41A18DD-1866-4BFB-93F1-F0BC52E536F5

P2093

Q41729344-02AC00F8-A11E-4250-954D-4DE42480BFBE

Q41729344-223769F1-12A4-45AA-9F70-859591B8CAEF

Q41729344-424DF6AA-88F0-4B61-8D9F-6C4CA60EA709

Q41729344-4F8EECB2-A76C-49E8-A973-010AAE73F508

Q41729344-68883263-9DF6-4F74-A154-DA1938F82E91

Q41729344-6C763739-6909-45D2-BFAD-85A20D0ED7D2

Q41729344-71BD5307-C66C-4CCB-84B2-E6827B50FBC5

Q41729344-A7506482-1E0C-4467-B219-67A2C172860C

Q41729344-A7A907C8-0469-4ED1-8B88-6C6BF0EA942A

Q41729344-AF2B410B-D3AC-4B90-A997-DDFBC1057C7B

P2860

Q41729344-1D74730C-1B71-427C-BEA1-4AA939888BC3

Q41729344-1EB89269-3790-4180-9E1F-CF7768AD9E93

Q41729344-26A95997-50BC-4EE6-A9A8-7770F065B334

Q41729344-30565848-AEF5-40BA-93F1-A9F5D83EE0AE

Q41729344-3212B487-2938-43B3-AEAB-E8BDEB8F8BF9

Q41729344-360198A5-7C1B-4597-82CE-1914DC30A8D2

Q41729344-45C5D225-23A8-493D-B295-04ECE4E8B0F1

Q41729344-57769EB7-587D-44B8-9F63-CA92F81235B3

Q41729344-5C99EABA-4950-427C-B294-3083D5CFEA78

Q41729344-7E143B2A-DBF1-46E2-8670-D9DA6FA182A7

P304

Q41729344-351C49BD-FF95-4520-B4FF-4ACA112BA301

P31

Q41729344-B733F53D-3D54-4479-9A53-CCCDB9ECF233

P356

Q41729344-75A0BBDE-A8AB-4F3B-9638-CA6F3FE86191

P407

Q41729344-E39A8B60-119C-4900-AF62-7D03AC690CCD

P433

Q41729344-CD132119-F0BC-47C9-908D-89AFA9E86210

P478

Q41729344-81ADA0F4-C86D-4CB9-A9EE-00EF237B1B54

P50

Q41729344-EFBE5316-B20E-455A-B94C-0EEF753CA965

P577

Q41729344-A71A411D-E4DA-4705-826E-AE543F4E479C

P698

Q41729344-92399994-C15E-46A9-AEA6-E0445A36C401

P921

Q41729344-6710FEAA-619E-443D-AB20-01ABD8F9A081

P356

THORAXJNL-2014-205587

P1433

P1476

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

@en

P2093

Alan F Barker

http://www.w3.org/2001/XMLSchema#string

Anthony De Soyza

http://www.w3.org/2001/XMLSchema#string

B-305 Study Investigators

http://www.w3.org/2001/XMLSchema#string

Brett Charlton

http://www.w3.org/2001/XMLSchema#string

Conor O'Dochartaigh

http://www.w3.org/2001/XMLSchema#string

Daniel C Chambers

http://www.w3.org/2001/XMLSchema#string

Diana Bilton

http://www.w3.org/2001/XMLSchema#string

Eric H J van Haren

http://www.w3.org/2001/XMLSchema#string

Gregory Tino

http://www.w3.org/2001/XMLSchema#string

Howard G Fox

http://www.w3.org/2001/XMLSchema#string

P2860

The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

New Zealand national incidence of bronchiectasis "too high" for a developed country.

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.

Bronchiectasis in Central Australia: a young face to an old disease.

British Thoracic Society guideline for non-CF bronchiectasis.

Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century.

Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.

P304

1073-1079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAXJNL-2014-205587

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25246664

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis